Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Last year's invitation to shareholder meeting
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Does anyone know if any proposals on the agenda are likely to be originated by a shareholder?

Is there a process or is it too late to add (or "request to be added") such an agenda item?

Also - wouldn't a By-Law change be a material event and that the before/after wording would need to be reported to SEC as such?

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply